LYNXICLAV Suspension is an oral antibiotic formulation used to treat a range of bacterial infections. It combines a penicillin-type antibiotic with a beta-lactamase inhibitor to help improve effectiveness against bacteria that produce resistance enzymes. This suspension form is commonly prescribed for children or individuals who have difficulty swallowing tablets, and it may be used for infections affecting the respiratory tract, ear, throat, skin, or urinary tract when caused by susceptible bacteria.

Active Ingredient(s) / Generic Name

• Amoxicillin

• Clavulanic Acid (as Potassium Clavulanate)
  Common strength (after reconstitution): Amoxicillin 200 mg / Clavulanic Acid 28.5 mg per 5 mL (strength may vary by product).

Brand Name / Manufacturer / Marketer
Brand: LYNXICLAV Suspension
Manufactured and marketed by a licensed pharmaceutical manufacturer in accordance with regulatory standards.

Indications / Uses
Indicated for the treatment of susceptible bacterial infections such as respiratory tract infections, ear and throat infections, skin and soft tissue infections, and certain urinary tract infections, when prescribed by a healthcare professional.

Storage Instructions
Store the dry powder below 30°C in a cool, dry place. After reconstitution, keep the suspension refrigerated (2–8°C) and use within the recommended period stated on the label. Keep out of reach of children.

Disclaimer
This information is provided for general educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare professional before using this medication.